Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation.

Anna Cinkajzlová, Miloš Mráz, Zdeňka Lacinová, Jana Kloučková, Petra Kaválková, Helena Kratochvílová, Pavel Trachta, Jarmila Křížová, Denisa Haluzíková, Jan Škrha, Hana Papežová, Martin Haluzík

Journal: Nutrition & diabetes 2019;8(1):21

PMID: 29695708

Abstract

BACKGROUND

Angiopoietin-like proteins (ANGPTLs) 3 and 4 are circulating factors that participate in the regulation of lipid and glucose metabolism.

SUBJECTS AND METHODS

We measured serum ANGPTL3 and 4 levels in 23 patients with obesity, 40 patients with obesity and type 2 diabetes mellitus (T2DM), 22 patients with anorexia nervosa (AN), 15 subjects undergoing 72-h fasting, and 12 patients with short bowel syndrome (SBS), and their changes after very-low-calorie diet (VLCD), bariatric surgery, partial realimentation, acute fasting, and parenteral nutrition in order to assess their possible role in metabolic regulations.

RESULTS

Serum ANGPTL4 levels were higher in obese subjects without/with T2DM (94.50 ± 9.51 and 134.19 ± 7.69 vs. 50.34 ± 4.22 ng/ml, p < 0.001) and lower in subjects with AN relative to healthy control subjects (38.22 ± 4.48 vs. 65.80 ± 7.98 ng/ml, p = 0.002), while serum ANGPTL3 levels demonstrated inverse tendency. Nutritional status had no effect on ANGPTL3 and 4 mRNA expression in adipose tissue. Fasting decreased ANGPTL3 and increased ANGPTL4 levels, while VLCD reduced only ANGPTL3. Bariatric surgery and realimentation of AN or SBS patients had no effect on either ANGPTL. Multiple regression analysis identified BMI as an independent predictor of ANGPTL3; and BMI and HbA as independent predictors of ANGPTL4, respectively.

CONCLUSIONS

Taken together, our data suggest that serum ANGPTL3 and 4 levels are influenced by nutritional status and fasting and could be involved in the metabolic disturbances present in obesity and AN.

Address: Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.; Department of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.; Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.; Third Department of Medicine-Department of Endocrinology and Metabolism, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.; Department of Sports Medicine, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.; Department of Psychiatry, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic.; Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. [email protected].; Department of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic. [email protected].; Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.